Indian Pharmacopoeia Commission – Autonomous Institution of the Ministry of Health and Family Welfare, Government of India
The Indian Pharmacopoeia Commission is an autonomous institution under the Ministry of Health & Family Welfare, Government of India. It is tasked with setting drug quality standards and monitoring safety through the Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI). In collaboration with NABH, IPC aims to streamline and strengthen adverse event reporting mechanisms in NABH-accredited hospitals, ensuring that ADRs and MDAEs are effectively captured, analysed, and reported to PvPI and MvPI respectively.
Effective monitoring and timely reporting of adverse drug and device events are critical to patient safety. This collaboration bridges the gap between healthcare delivery and national pharmacovigilance systems, ensuring data-driven policy making and improving clinical safety standards.
To promote and strengthen the monitoring and reporting of Adverse Drug Reactions (ADR) and Medical Device Associated Adverse Events (MDAE) by NABH-accredited hospitals to PvPI and MvPI, respectively.
- Improves patient safety through timely identification of adverse events
- Creates a structured feedback mechanism for national safety databases
- Enhances hospital compliance with pharmacovigilance and materiovigilance norms
- Contributes to safer use of medicines and medical devices nationwide